The increasing expression of B7-H6 was associated with increasing NK cell activation via NKp30 expression, corresponding to higher soluble forms of B7-H6 levels in the sera of patients with high-risk neuroblastoma. The gene discussed is NCR3; the disease is neuroblastoma.